1209 related articles for article (PubMed ID: 11289656)
1. An investigation of cell proliferation and soluble mediators induced by interleukin 1beta in human synovial fibroblasts: comparative response in osteoarthritis and rheumatoid arthritis.
Inoue H; Takamori M; Nagata N; Nishikawa T; Oda H; Yamamoto S; Koshihara Y
Inflamm Res; 2001 Feb; 50(2):65-72. PubMed ID: 11289656
[TBL] [Abstract][Full Text] [Related]
2. Regulation by PGE2 of the production of interleukin-6, macrophage colony stimulating factor, and vascular endothelial growth factor in human synovial fibroblasts.
Inoue H; Takamori M; Shimoyama Y; Ishibashi H; Yamamoto S; Koshihara Y
Br J Pharmacol; 2002 May; 136(2):287-95. PubMed ID: 12010778
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous requirement of IkappaB kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis: implications for therapy.
Andreakos E; Smith C; Kiriakidis S; Monaco C; de Martin R; Brennan FM; Paleolog E; Feldmann M; Foxwell BM
Arthritis Rheum; 2003 Jul; 48(7):1901-12. PubMed ID: 12847684
[TBL] [Abstract][Full Text] [Related]
4. Kaempferol inhibits IL-1β-induced proliferation of rheumatoid arthritis synovial fibroblasts and the production of COX-2, PGE2 and MMPs.
Yoon HY; Lee EG; Lee H; Cho IJ; Choi YJ; Sung MS; Yoo HG; Yoo WH
Int J Mol Med; 2013 Oct; 32(4):971-7. PubMed ID: 23934131
[TBL] [Abstract][Full Text] [Related]
5. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.
Nakahara H; Song J; Sugimoto M; Hagihara K; Kishimoto T; Yoshizaki K; Nishimoto N
Arthritis Rheum; 2003 Jun; 48(6):1521-9. PubMed ID: 12794819
[TBL] [Abstract][Full Text] [Related]
6. Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures.
Fearon U; Mullan R; Markham T; Connolly M; Sullivan S; Poole AR; FitzGerald O; Bresnihan B; Veale DJ
Arthritis Rheum; 2006 Oct; 54(10):3152-62. PubMed ID: 17009243
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of NFkappaB-mediated interleukin-1beta-stimulated prostaglandin E2 formation by the marine natural product hymenialdisine.
Roshak A; Jackson JR; Chabot-Fletcher M; Marshall LA
J Pharmacol Exp Ther; 1997 Nov; 283(2):955-61. PubMed ID: 9353419
[TBL] [Abstract][Full Text] [Related]
8. Neurotransmitter modulation of interleukin 6 (IL-6) and IL-8 secretion of synovial fibroblasts in patients with rheumatoid arthritis compared to osteoarthritis.
Raap T; Jüsten HP; Miller LE; Cutolo M; Schölmerich J; Straub RH
J Rheumatol; 2000 Nov; 27(11):2558-65. PubMed ID: 11093434
[TBL] [Abstract][Full Text] [Related]
9. Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis.
Gui H; Liu X; Wang ZW; He DY; Su DF; Dai SM
Rheumatology (Oxford); 2014 May; 53(5):802-9. PubMed ID: 24440992
[TBL] [Abstract][Full Text] [Related]
10. Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1beta.
Jackson JR; Minton JA; Ho ML; Wei N; Winkler JD
J Rheumatol; 1997 Jul; 24(7):1253-9. PubMed ID: 9228120
[TBL] [Abstract][Full Text] [Related]
11. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
Woolley DE; Tetlow LC
Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
[TBL] [Abstract][Full Text] [Related]
12. [Effects of RNAi on cyclooxygenase-2 expression and biologic activity of human rheumatoid arthritis synovial fibroblasts].
Jiang LD; Wang HZ; Zhao FD; Guo JS; Bao CD; Zou HJ; Wang JY
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2925-8. PubMed ID: 18261308
[TBL] [Abstract][Full Text] [Related]
13. Amplification of the synovial inflammatory response through activation of mitogen-activated protein kinases and nuclear factor kappaB using ligation of CD40 on CD14+ synovial cells from patients with rheumatoid arthritis.
Harigai M; Hara M; Kawamoto M; Kawaguchi Y; Sugiura T; Tanaka M; Nakagawa M; Ichida H; Takagi K; Higami-Ohsako S; Shimada K; Kamatani N
Arthritis Rheum; 2004 Jul; 50(7):2167-77. PubMed ID: 15248214
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts.
Hitchon C; Wong K; Ma G; Reed J; Lyttle D; El-Gabalawy H
Arthritis Rheum; 2002 Oct; 46(10):2587-97. PubMed ID: 12384916
[TBL] [Abstract][Full Text] [Related]
15. The effects of 1 alpha,25-dihydroxyvitamin D(3) on matrix metalloproteinase and prostaglandin E(2) production by cells of the rheumatoid lesion.
Tetlow LC; Woolley DE
Arthritis Res; 1999; 1(1):63-70. PubMed ID: 11056661
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts.
Honorati MC; Neri S; Cattini L; Facchini A
Osteoarthritis Cartilage; 2006 Apr; 14(4):345-52. PubMed ID: 16311048
[TBL] [Abstract][Full Text] [Related]
17. Regulation of interleukin-1beta-induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts.
Ahmed S; Pakozdi A; Koch AE
Arthritis Rheum; 2006 Aug; 54(8):2393-401. PubMed ID: 16869002
[TBL] [Abstract][Full Text] [Related]
18. Preferential induction of prodestructive matrix metalloproteinase-1 and proinflammatory interleukin 6 and prostaglandin E2 in rheumatoid arthritis synovial fibroblasts via tumor necrosis factor receptor-55.
Alsalameh S; Amin RJ; Kunisch E; Jasin HE; Kinne RW
J Rheumatol; 2003 Aug; 30(8):1680-90. PubMed ID: 12913922
[TBL] [Abstract][Full Text] [Related]
19. Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1.
Grall F; Gu X; Tan L; Cho JY; Inan MS; Pettit AR; Thamrongsak U; Choy BK; Manning C; Akbarali Y; Zerbini L; Rudders S; Goldring SR; Gravallese EM; Oettgen P; Goldring MB; Libermann TA
Arthritis Rheum; 2003 May; 48(5):1249-60. PubMed ID: 12746898
[TBL] [Abstract][Full Text] [Related]
20. Protein tyrosine phosphatase nonreceptor type 2: an important regulator of lnterleukin-6 production in rheumatoid arthritis synovial fibroblasts.
Aradi B; Kato M; Filkova M; Karouzakis E; Klein K; Scharl M; Kolling C; Michel BA; Gay RE; Buzas EI; Gay S; Jüngel A
Arthritis Rheumatol; 2015 Oct; 67(10):2624-33. PubMed ID: 26139109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
